Evidence map›Paper›PMID 33824282›Full record

ArticleCell death & disease2021

ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression.

Huojian Shen, Hongyi Zhu, Yuanwen Chen, Zhiyong Shen, Weiqing Qiu, Changlin Qian, Jie Zhang

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. IGF2BP2: an mCellular & molecular biology letters · 2025
    Review
  8. Article
  9. Article
  10. IMPlications of IMP2 in RNA Biology and Disease.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Sialylation-immune-related lncRNAFrontiers in immunology · 2025
    Article
  16. Review
  17. Article
  18. IGF2BPs as novel mGenes & diseases · 2024
    Review
  19. Article
  20. NJournal of translational internal medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huojian Shen *Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Hongyi Zhu *Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Yuanwen ChenRenji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Zhiyong ShenRenji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Weiqing QiuRenji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Changlin QianRenji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China.
Jie ZhangRenji Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200025, China. Zhangjie153000@163.com.
Renji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is a common type of tumor that is characterized with high metastatic rate. In recent years, increasing studies have indicated that lncRNAs are involved in the regulation on cancer cell proliferation and migration. However, the functional role of long intergenic non-protein coding RNA 1559 (LINC01559) in GC is still unclear. In this study, we applied quantitative real-time polymerase chain reaction (RT-qPCR) and examined that LINC01559 expression was significantly enhanced in GC cells. Functional assays such as EdU, colony formation, JC-1 and transwell assays displayed that silencing LINC01559 inhibited cell proliferation and migration while promoted cell apoptosis in GC. Besides, western blot analysis and immunofluorescence assays examined the expression of factors related to epithelial-mesenchymal transition (EMT) and indicated that EMT process was blocked by LINC01559 knockdown in GC cells. Besides, LINC01559 silencing inhibited tumor growth in vivo. In addition, Chromatin immunoprecipitation (ChIP) assays demonstrated that zinc finger E-box binding homeobox 1 (ZEB1) served as a transcription factor to combine with LINC01559 promoter and activated the expression of LINC01559 in GC cells. In return, LINC01559 recruited insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) to stabilize ZEB1 mRNA to up-regulate ZEB1 in GC cells. In short, the findings in this research might provide a novel target for GC treatment.

Indexed as

Cell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansRNA-Binding ProteinsRNA, Long NoncodingStomach NeoplasmsZinc Finger E-box-Binding Homeobox 1IGF2BP2 protein, humanRNA-Binding ProteinsRNA, Long NoncodingZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID33824282
PMCPMC8024305
OpenAlexW3145266916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.